BUZZ - Halozyme shares rise after winning a case against Merck's injectable Keytruda in a Dutch court
路透社2026/10/07 13:31October 7 – Halozyme (HALO.O) shares rose 1.4% pre-market to $111.24. Halozyme announced it had obtained an injunction from a Dutch court (link), prohibiting Merck MRK.N from manufacturing, selling, and importing subcutaneous Keytruda in eight European markets. The court determined that Merck had infringed Halozyme’s EP622 patent and rejected Merck’s claims that the patent was invalid. Halozyme stated that patients will still have access to the intravenous version of Keytruda, which is not affected by the injunction. As of the close of the previous trading day, HALO shares have risen 62% this year. (For non-English speakers, Reuters automatically translates its reports into several languages. Due to possible errors or missing context in automated translations, Reuters does not guarantee the accuracy of such translated texts, which are provided for readers’ convenience only. Reuters assumes no liability for any damages or losses caused by use of the automated translation function.)
October 7 - ** Halozyme (HALO.O) shares rose 1.4% pre-market to $111.24
** Halozyme stated it has obtained an injunction (link) from a Dutch court prohibiting Merck MRK.N from manufacturing, selling, and importing subcutaneous Keytruda in eight European markets
** The court ruled that Merck infringed Halozyme's EP622 patent and rejected Merck's claim that the patent was invalid
** Halozyme noted that patients can still access the intravenous form of Keytruda, which is not affected by the injunction
** As of the close of the previous trading session, HALO is up 62% year-to-date
(To assist non-native English speakers, Reuters provides automated translations of its reports in several other languages. Automated translation may contain errors or lack the necessary context; Reuters does not guarantee the accuracy of automated translation and provides it solely for the convenience of readers. Reuters assumes no responsibility for any harm or losses arising from the use of automated translation.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
VIP Play extends maturity on 12% convertible notes held by Hackel, Access Fund I LP
Vip Play amended convertible note purchase agreements with Rick Hackel, The Access Fund I, LP, extending maturity dates. Hackel notes totaling $300,000 now mature Feb. 28, 2027; Access note of $150,000 now matures Aug. 31, 2027. Notes carry 12% annual interest; principal and accrued interest due in a single balloon payment unless converted to common stock. Changes take effect Sept. 1, 2026; amendments or waivers now require only the company and the relevant noteholder. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vip Play Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-046094), on October 07, 2026, and is solely responsible for the information contained therein.
MTY Food Group Faces Near-Term Headwinds Ahead of 3Q Results -- Market Talk
1019 ET - MTY Food Group faces persistent macroeconomic headwinds and high uncertainty driven by intense quick-service restaurant competition. RBC's Ryland Conrad says in a report that uncertainty hinges around the scope, probability, timing and valuation of any potential transaction around MTY's ongoing strategic review, now in its tenth month. While an outcome could act as a catalyst for the stock, "sustained macro and competitive headwinds to limit any meaningful improvement in the near term." As a result, Conrad says the "focus remains on MTY's organic growth trajectory" where management continues improving and strengthening its network. The company is expected to report its 3Q results on Oct. 9. (adriano.marchese@wsj.com) (END) Dow Jones Newswires October 07, 2026 10:19 ET (14:19 GMT)
US Stock Movement | Optical Communication Concept Stocks Fall, Applied Optoelectronics (AAOI.US) Drops Over 6%
On Wednesday, optical communication concept stocks generally declined, with Applied Optoelectronics (AAOI.US) dropping more than 6%.
Euro: Recovery holds as currency softens – BNY
Crypto prices
More
